| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |